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Invasive duct carcinomaSummary Nearly 80% of well-differentiated in situ duct carcinomas (g1 DCIS) have been shown to be
multicentric (multilobar) lesions, while most in situ poorly differentiated duct carcinomas (g3 DCIS)
were unifocal (unilobar) lesions. Here we present a clonality study of 15 cases of DCIS, all showing
multiple foci. Twelve of these cases were associated with an invasive duct carcinoma. Fifteen cases of
female breast cancer patients all showing multiple DCIS foci (5 g1 DCIS, 5 g2 DCIS, 5 g3 DCIS) were
randomly selected and histologically studied using large histological sections. Care was taken to laser-
microdissect DCIS foci that were most distantly located from one another in the same large section, and
pertinent cells were genetically studied. Invasive duct carcinoma and ipsilateral lymph node metastases
and/or contralateral lesions, whenever present, were additionally microdissected. DNA of neoplastic
cells was purified, and the mtDNA D-loop region was sequenced. Genetic distance of different foci from
the same case was visualized by phylogenetic analyses using the neighbor-joining method. Patients
ranged in age from 36 to 87 years (mean 65.1). All 9 cases of widely spread DCIS were not clonal. Four
of 6 cases that showed multiple adjacent foci were clonally related on mtDNA analysis. In the present
series, 11/15 DCIS appeared as multiple synchronous primary breast tumors, genetically not related to
one another. The present data enhance the view that breast can also show the field cancerization
phenomenon, paralleling what has already been proposed in other organs.
© 2013 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction direct visualization of a large part of the breast glandular treeLarge histological sections (LHS) are very useful to study
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Open access under CC BY-NC-ND license.in one plane and enhance not only the correlation between
mammography and pathology [2], but also give pertinent
reliable information on multifocality, difficult to obtain using
conventional paraffin blocks [3,4]. The breast parenchyma is
subdivided into lobes, which are individual anatomical
structures [5], each formed by a single galactophore duct that
branches into segmental, subsegmental and terminal ducts,
1311Field cancerization of duct breast carcinomaall ending in numerous acini [6]. Terminal ducts together
with their relative acini have been named the “terminal duct
lobular unit” (TDLU) [7]. Utilizing LHS, it has been shown
that in situ and invasive lobular carcinoma is a multifocal [8]
neoplastic lesion in over 50% of cases [9]. A study of 45
patients with in situ duct carcinoma (DCIS) using LHS for
multifocality [3] showed that grade 1 DCIS was, in nearly
80% of the cases, a widespread multifocal condition
involving more than one lobe and/or quadrant, while grades
2 and 3 DCIS were more circumscribed lesions, mostly
confined to one lobe. It was then stated that grade 1 DCIS, in
terms of multifocality, was more similar to previous
observations regarding lobular in situ neoplasia/lobular in
situ carcinoma (LIN2/LIN) [3,9].
In a seminal study using LHS on a series of 574 consecutive
newly diagnosed breast carcinomas, Tot et al [10] found 75
cases (13%) of pure DCIS, of which 12% were unifocal
(involving a single TDLU), 10% multifocal (involving several
distant TDLUs with uninvolved breast tissue in between) and
24% diffuse (mainly involving large ducts). In the same study,
invasive duct carcinomas (IDC) were unifocal in 62% of cases,
multifocal in 24% and widely spread in 5%.
The reported incidence of multifocality (and multicen-
tricity) of DCIS ranges from 0% to 78% according to different
authors [11] to the point that multicentricity was denied by
Page et al. [12], who stated that it is a misconception mostly
related to artifacts. These remarkably different results for
assessing the presence of multiple neoplastic foci in the same
breast, obtained by different authors, appear to depend on the
various methods of study employed, mostly based on
traditional multiple-block sampling.
Although multifocality has been interpreted as the simul-
taneous presence of different neoplastic primaries in different
lobes [3], it was felt [9] that some cases escape this rule due to
the complexity of the ductal breast tree [5]. In fact, there are
lobes that spread over a wide space and can mix with adjacent
lobes to such an extent that it is impossible to separate one from
the other at the morphological level, even using LHS [5].
The aim of this study was to try to find common or
different mitochondrial DNA (mtDNA) mutations among
multifocal DCIS that might reflect clonal or nonclonal
features. The study was also extended to concurrent invasive
carcinomas as well as metastases to axillary lymph nodes.
For clonality, point mutations of the hypervariable D-loop
region of mtDNA were studied by deep sequencing.
Mutations were evidenced with phylogenetic analysis of
neighbor-joining (NJ) trees [4,13].2. Materials and methods
2.1. Patients
Fifteen randomly selected female patients, ranging in age
from 36 to 87 years (mean 65.1) were included in the presentstudy. All patients had undergone mastectomies histologi-
cally studied with LHS. Criteria for selection of cases were
the following: (a) multiple TDLUs/ducts involved by DCIS
present within the same LHS; (b) enough material for
microdissection and molecular analysis; (c) 5 cases each of
g1 DCIS, g2 DCIS and g3 DCIS [14].
DCIS was graded according to current (2012) World
Health Organization (WHO) criteria [11]. IDC, when
present, was graded according to Elston and Ellis [15].
Nodal metastases, recurrences and contralateral lesions
whenever present, were studied for clonal mtDNA analysis.
DCIS, per Tot's criteria [10,16], were considered unifocal
when they involved several adjacent TDLUs, multifocal if
they involved several distant TDLUs with uninvolved breast
tissue in between, possibly containing normal glandular
structures, and diffuse when large ducts were involved. IDC
was considered unifocal when only one invasive area was
observed in the large section, while it was considered
multifocal when multiple invasive tumor areas were
observed separated by uninvolved nonneoplastic breast
tissue [10,16]. No cases of diffuse IDC or invasive lobular
carcinoma or LCIS/LIN were present.
2.2. Tissue processing
Parallel large 5 mm thick slices were obtained from each
mastectomy specimen, a routine procedure in our laboratory
since 1995 [1]. Care was taken to slice each section
perpendicularly to the skin, under mammographic guidance.
Slices were then fixed in 10% buffered formalin and
paraffin embedded as routine. From each large paraffin
block, one 8 μm hematoxylin and eosin–stained section was
obtained [1].
2.3. Microdissection
Two to 7 foci of DCIS from each case were laser-
microdissected for genetic study. Care was taken in capturing
foci that were located at the farthest distance from one
another in the same LHS.
Pertinent lesions were microdissected using the laser
assisted SL μcut Microtest (MMI GmbH distributed by
Nikon, Firenze, Italy). Ten-μm-thick sections were obtained,
and unstained sections were deparaffinized with Bio-Clear
(Bio-optica, Milan, Italy), rinsed in 100% to 80% ethanol and
stained with hematoxylin and eosin. Breast glandular or
epithelial tissue uninvolved by the neoplastic process and/or
lymphocytes from reactive lymph nodes from the same case
were also microdissected as control reference DNA. Tissue
for microdissection from a pertinent block inclusive of the
selected lesion was obtained from LHS. The block was
melted and re-embedded to obtain the slide useful for the
laser dissecting microscope.
The microdissected cells were placed in SL μcut Transfer
Film (Nikon, Firenze, Italy), and the DNA was digested
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QIAamp DNA Micro Kit, Qiagen GmbH, Hilden, Germany)
containing 20 μL of proteinase K provided by the same
supplier. A yeast carrier tRNA (Invitrogen, Milan, Italy) was
added to the sample to improve DNA affinity with the
subsequent isolation by Qiagen Spin Column (QIAamp
DNA Micro Kit). Finally, DNA was eluted in 40 μL of
ultrapure distilled water (DNAse/Rnase-free, Invitrogen) and
immediately processed for polymerase chain reaction (PCR).
An extraction control, to which no tissue was added, was
processed in parallel with each sample extraction.
2.4. mtDNA deep sequencing and neighbor joining
tree creation
DNA was purified and sequenced for the mtDNA D-loop
region by the 454 Platform (GSJunior; Roche, Branford,
CT). In brief, the mtDNA D-loop sequence analysis was
performed by amplifying four segments of about 400 bp,
covering the whole region from position 15995 to position
700, according to Anderson et al [17] as described in the
human mitochondrial database [18]. Primers were designed
using Primer3 [19], and their sequences are reported asTable 1 Clinical features of DCIS cases
Case DCIS grade Age (y) Side Concomitant IDC
1 g1 77 L absent
2 g1 57 R IDC g1
IDC g2
3 g1 52 R absent
4 g1 81 R IDC g2
5 g1 74 L IDC g2
6 g2 87 L absent
7 g2 63 R IDC g2
8 g2 83 R IDC g3
9 g2 68 L IDC g2
10 g2 47 L IDC g2
11 g3 65 L IDC g3
12 g3 51 L IDC g3
13 g3 57 R IDC g3
14 g3 36 L IDC g2
15 g3 78 L IDC g3
Abbreviations: g, grade; DCIS, ductal carcinoma in situ; R, right side; L, left side;
invasive duct carcinoma; CLT, contralateral breast; MTS, metastases.Supplementary Table 1. These primers were selected to
avoid amplification of human mitochondrial pseudogenes in
the nuclear genome [20]. To generate amplicons for the 454
NGS library, fusion primers were designed to contain
specific mtDNA primers, the A and B sequencing adapters
and the key sequence required for 454 NGS, and one of 14
different 10 bp multiplex identifier barcodes, according to
the manufacturer's GS FLX Standard sequencing method.
PCR reactions were performed in a 25 μL volume
containing 5 pmol of each forward and reverse primer using
KAPA HiFi HotStart DNA Polymerase, following the
instructions of the provider (Kapa Biosystems, Woburn,
MA). PCR products were separated by electrophoresis on
3% agarose gel and purified using the AmpPure kit
(Agencourt; Beverly, MA). Sequencing analysis was then
performed on purified products using the GS Junior
sequencer (Roche; Branford, CT) following the recommen-
dations of the provider. The strands were screened
bidirectionally. Filters were set to display sequence variances
occurring in at least 10 reads with a threshold of 10% mutant
reads using Amplicon Variant Analyzer (v. 2.7, Roche).
Phylogenetic and cluster analyses were conducted using
MEGA version 4.0 following the NJ method and Kimura-2Ln status CLT Follow-up
N0 absent Alive and well
6 y
N0 IDC g3, N0
synchronous
Alive and well
11 y
N0 IDC g1, DCIS,
N+ 2 y earlier
Alive and well
10 y
N0 absent Died of other causes
N0 absent Alive and well
6 y
N0 IDC g2, N0
1 y earlier
Died of other causes
N+ absent Lung and bone MTS
5 y later
N+ absent Died of other causes
N+ absent Local skin recurrences
1 and 2 y later
N0 absent Alive and well
6 y
N+ absent Alive and well
2 y
N0 absent Alive and well
5 y
N+ absent Alive and well
2 y
N0 absent Alive and well
4 y
N+ absent Abdominal Ln and liver MTS
10 mo later
Ln, lymph node; N0, lymph node negative; N+, lymph node positive; IDC,
Table 2 Histological features and molecular results of mtDNA analysis
Case DCIS
grade
Max distance
(mm)
Focality mtDNA
DCIS-DCIS IDC-DCIS MTS, CLT, REC
1 1 48 Multi Not clonal na na
2 1 50 Multi Not clonal IDC related to closer DCIS CLT not related to index lesions
3 1 46 Multi Not clonal na CLT DCIS, CLT IDC, CLT MTS not related
to index lesions but related among them
4 1 26 Multi Not clonal IDC related to closer DCIS na
5 1 12 Multi Not clonal IDC related to closer DCIS na
6 2 72 Multi Not clonal na CLT not related to index lesions
7 2 35 Uni Not clonal IDC related to closer DCIS MTS related to IDC
8 2 8 Uni Clonal IDC related to both DCIS MTS not related to index lesions
9 2 30 Multi Not clonal IDC related to distant DCIS MTS, REC not related to index lesions
but related among them
10 2 26 Multi/Diff Not clonal IDC related to distant DCIS na
11 3 30 Uni Clonal IDC not related to DCIS MTS related to IDC
12 3 28 Uni Clonal IDC related to both DCIS na
13 3 60 Uni Clonal IDC related to both DCIS MTS not related to index lesions
14 3 29 Multi Not clonal IDC related to closer DCIS na
15 3 30 Uni Not clonal IDC related to distant DCIS MTS related to IDC
Abbreviations: DCIS, ductal carcinoma in situ; Uni, unifocal; Multi, multifocal; Diff, diffuse; IDC, invasive duct carcinoma; MTS, metastases; CLT,
contralateral breast; REC, recurrence; na, not applicable.
1313Field cancerization of duct breast carcinomaparameter with Gamma model that corrects for multiple
hits, taking into account transitional and transversional
substitution rates and differences in the sites' substitution
rates [13,21-23]. Every NJ tree was tested for standard error
using the bootstrap method [13]. The genetic relationship
among samples was determined taking into account
their position in the phylogenetic tree together with the
length of terminal branches, all regarded markers of genetic
distance [23].
Multiple DCIS were considered clonal when they
appeared to derive from the same tree node or if their tree
path showed at the most one additional node with minimal
branch length. Nonclonal DCIS samples were located in
different branches of the root node or their path showed at
least 2 different nodes. Samples of IDC as well as lymph
node metastases were considered related or not related to the
index DCIS or to each other taking into account their
localization in the tree as well as branch lengths.3. Results
The 15 patients here studied were female, ranging in age
from 36 to 87 years (mean 65.1 years). The left breast was
involved in 9, and the right in 6 cases. Mastectomies were
preceded by preoperative vacuum-assisted core biopsies all
diagnosed as B5 [14]. IDC was observed in 12 cases, and 6
cases had synchronous axillary nodal metastases. Follow-up
was obtained in all cases, ranging from 1 to 11 years (mean
4.2 years). Two recurrences of invasive carcinoma were seen
in case 9 at 12 and 24 months. Two cases presented distantmetastases (cases 7 and 15 after 60 and 10 months,
respectively). Contralateral DCIS and IDC were seen in 3
cases (cases 2, 3 and 6). Case 2 was synchronous, while cases
3 and 6 had previous contralateral tumors diagnosed,
respectively, 24 and 12 months earlier (Table 1).3.1. Histology of DCIS
Multiple TDLUs/ducts involved by DCIS were present in
all cases as this was one of the selection criteria. DCIS
showed the same histological grade in every one of the
several TDLUs/ducts present within the same LHS (Table 2).
Eight cases (5 grade 1, 2 grade 2 and 1 grade 3) were
multifocal, that is, located in several TDLUs separated by
uninvolved breast glandular tissue, and one was multifocal
and diffuse (case 10). The maximum distance between the
involved ducts ranged from 12 to 72 mm (mean, 37.7 mm).
Six cases (2 grade 2 and 4 grade 3) were considered unifocal
because no uninvolved glandular tissue was present between
the involved ducts. In these latter 6 cases, the maximum
distance between the involved ducts ranged from 8 to 60 mm
(mean, 31.8 mm).
Twelve cases showed concomitant areas of IDC, which
was unifocal in all but one (case 2) that showed 2 different
areas of IDC separated by uninvolved breast glandular tissue.
3.2. mtDNA analysis
mtDNA analysis results have been summarized in
Table 2, and complete phylogenetic trees are available in
Supplementary Figures 1-3.
Fig. 1 Case 3: well differentiated DCIS. M1 and M2 are the areas of the microdissected in situ lesions, 46 mm apart. DCIS in M1 and M2 do
not appear clonal in the phylogenetic tree as they are located in a different root branch. M3 and M4 are the microdissected areas of the invasive
lesions on the contralateral breast. All contralateral lesions (DCIS, IDCs and LN MTS) are not related to the above DCIS lesions but are
clonally related each other. Abbreviations: M, area of microdissection; DCIS, ductal carcinoma in situ; CLT, contralateral; IDC, invasive duct
carcinoma; LN MTS, lymph node metastases; REF, reference tissue.
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Fig. 2 Case 6: DCIS with intermediate differentiation. M1 and M2 are the areas of the microdissected in situ lesions, 72 mm apart. DCIS in
M1 andM2 do not appear clonal in the phylogenetic tree as they are located in a different root branch. The contralateral IDC is not related to the
above neoplastic lesions. Abbreviations: M, area of microdissection; CLT, contralateral; REF, reference tissue.
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NJ trees derived from the deep sequencing of mitochon-
drial genome from all 8 cases classified as multifocal and
case 10 classified as multifocal and diffuse on histology
showed that the most distant foci were located in distant
branches indicating phylogenetically different lesions
(Figs. 1 and 2).
3.2.2. Unifocal DCIS
In 4 out of 6 cases (cases 8, 11, 12, 13) classified as
unifocal on histology, the multiple dissected foci appeared
phylogenetically similar (Fig. 3). In the remaining two
cases (cases 7 and 15), the multiple foci were phylo-
genetically distant.
3.2.3. IDC
Eleven out of 12 cases showing IDC areas evidenced the
invasive lesion phylogenetically related to at least one DCIS
focus. Among these clonally related cases, 5 cases (cases 2,
4, 5, 7, 14) showed IDC phylogenetically related to the closer
DCIS focus, and 3 cases (cases 8, 12, 13) showed IDC
phylogenetically related to both foci of DCIS examined (the
closest and the most distant). The only exception was case
11, where the IDC area appeared phylogenetically not related
to the DCIS; nevertheless, the IDC area was located in a
different quadrant with respect to the DCIS in this case.
3.2.4. Contralateral carcinomas
All the lesions located in the contralateral breast in cases
2, 3 and 6 were phylogenetically distant from their index
lesions. In case 3, contralateral DCIS, IDC and axillary nodal
metastases were phylogenetically related each other and
different from the index lesion.
Lymph node metastases were located in a branch close to
the related IDC in 3 out of 6 cases, while in three cases, they
were phylogenetically distant from the related IDC. Skin
recurrences of case 9 were related to the nodal metastasis.4. Discussion
Several methods can be applied to evaluate clonality in
tumor pathology. In the present study, the clonality assay
was performed by mtDNA (D-loop) sequence analysis
followed by neighbor-joining tree, which has been repeat-
edly validated in our laboratory [4,24-26]. This approach
was chosen as it is little affected by low-quality genetic
material obtained from formalin and paraffin embedded
tissues that hamper consistent results from the other
commonly used methods, including array comparative
hybridization and X-linked methylation analysis. In addition,
nuclear genetic aberrations can give selective advantage to a
tumor population and therefore the same changes can be
found at the same time in different clones [27]. Furthermore,
the analysis of a noncoding region like mtDNA D-loop isbased on functionally silent mutations that are useful to
indelibly mark each cell with a unique genetic fingerprint
[28]. The high level of mutation rate in mtDNA also helps to
increase the confidence of the test, avoiding false positive
results stochastically obtained, as demonstrated by the
bootstrap test [4,13].
Based on clonal analysis evaluated by mtDNA analysis,
in the present series, all cases that were classified as
multifocal DCIS on morphology appeared to be genetically
different as the single DCIS foci were not clonally related to
each other. On the contrary, 4 out of 6 cases regarded
unifocal appeared to be clonal as the single DCIS foci were
genetically related one another. Only 2 cases (cases 7 and 15)
of the present series were exceptions to this rule. In spite of
the fact that all the DCIS foci were contiguous, they did not
appear to be clonally related. Therefore, in the present series,
11 out of 15 nonclonal DCIS can be considered multiple
independent primary carcinomas.
The present data of multiple primary carcinomas suggest
that the breast can be affected by the phenomenon called
“field cancerization” by analogy with other organs [29,30].
The term “field cancerization” was introduced in 1953 by
Slaughter and co-workers [31] to explain the presence of
multiple squamous cell carcinomas observed in different
areas of the oral cavity, all associated with a preneoplastic
lesion. This observation has recently been confirmed by
molecular techniques [32-34]. The same observation has
since been found applicable to several organs, including the
breast, to explain simultaneous multiple primaries [30].
The breast can be affected by multiple cancers located in
different quadrants [11]. Eleven of the present DCIS were
nonclonal, multiple independent in situ neoplasms. Similar
results were shown by Volante et al [35], who found that two
cases of low-grade DCIS and 6 cases of lobular in situ
carcinoma appeared nonclonally related. Bilateral invasive
breast carcinomas when associated to DCIS are considered
independent primary tumors [11]. This view is in keeping
with case 2, which showed 2 distinct bilateral invasive
carcinomas with different morphology (one case was IDC
grade 2, while the second area was grade 1). Both carcinomas
were nonclonal but contained a genetically related DCIS. The
same condition was observed evaluating contralateral
carcinomas (cases 2, 3, 6), which appeared to be not clonally
related to the index lesions.
In organs where the concept of field cancerization has
been accepted for a long time, the epithelium surrounding the
invasive carcinoma often shows the features of pre-
neoplastic lesions. The same features can be observed in
the breast where the in situ carcinoma is frequently
associated with invasive carcinoma. In a previous study on
the three-dimensional reconstruction of invasive and in situ
lobular carcinoma, it has been shown that 78.6% of the areas
of invasive lobular carcinoma contained concomitant foci of
in situ lobular carcinoma [9]. Similarly, a frequent
association between IDC and concomitant DCIS in the
same area has been demonstrated by the same group [3]; the
Fig. 3 Case 11: poorly differentiated DCIS. M1 and M2 are the areas of the microdissected in situ lesions, 30 mm apart. An area of g3 IDC
(M3) is not included in the picture as it was present in another quadrant. DCIS in M1 and M2 appear clonal in the phylogenetic tree as they
cluster in the same branch. IDC as well as LN metastases appear located in a different root branch. They are related each other, but not related
to the in situ lesions. Abbreviations: M, area of microdissection; DCIS, ductal carcinoma in situ; IDC, invasive duct carcinoma; LN MTS,
lymph node metastases; REF, reference tissue.
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Aulmann et al [36] using molecular techniques. These
authors demonstrated that in situ and invasive breast
carcinoma, when intermingled together, are clonal lesions,
thus confirming the strict relationship between concomitant
in situ and invasive carcinomas [4,26]. Pertinently, in the
present series, IDC areas were clonally related with at least
one focus of DCIS.
Slaughter and coworkers [31] observed that in some
cases, microscopic tumor foci grow independently and
finally coalesce to produce a large carcinomatous lesion. In
case 7 of the present series, DCIS and IDC, microdissected
at the 2 opposite edges of the same wide neoplastic area,
were composed of neoplastic clones not genetically related to
each other.
Finally, in the field cancerization model of the oral cavity,
after surgical removal of an invasive carcinoma, pre-
neoplastic lesions might not be excised, thus developing
into invasive carcinomas [32]. The same has been demon-
strated in the breast by several studies performed indepen-
dently using different molecular techniques that revealed
genetic alterations in apparently normal glandular structures
located around breast carcinomas [37].
The evaluation of the extent of mammary field canceriza-
tion is still open to question. According to Tot [6], breast
carcinoma arises in a genetically altered mammary lobe and
develops mainly along the lobar ducts and TDLUs. Cases 8,
11, 12 and 13 of the present series were characterized by
multiple DCIS foci not separated by normal glandular
structures. They all appeared clonally related, indicating that
the carcinoma extended through the branches of the same
lobe. Therefore it appears that in these cases the extent of the
cancerized field might only be one lobe. In contrast, the cases
presenting multifocal DCIS foci not clonally related on
mtDNA analysis might represent involvement of multiple
lobes, indicating a wider cancerized field. This latter event
appears more frequent in cases of grade 1 DCIS.
In conclusion, the data here obtained indicate the following:
1. Most multifocal DCIS are phylogenetically distant,
nonclonal lesions, which might indicate different syn-
chronous primaries in different lobes of the same breast.
2. Contralateral DCIS and IDC were phylogenetically
different from the index lesions. These data are probative
for independent primaries of both breasts.
3. IDC phylogenetically close to concomitant DCIS is
highly suggestive that the latter is a precursor.
4. All these data indicate that the breast can be affected by
field cancerization.Supplementary data
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.humpath.2012.09.022.Acknowledgments
Elisa Leonardi is recipient of a grant from Susan G.
Komen Italia (Rome). Dr Christine M. Betts has kindly read
and revised the manuscript.References
[1] Foschini MP, Tot T, Eusebi V. Large-section (macrosection) histologic
slides. In: Silverstein MJ, editor. Ductal carcinoma in situ of the breast.
2nd ed. Philadelphia: Lippincott; 2002. p. 249-54.
[2] Tot T, Tabar L. The role of radiological-pathological correlation in
diagnosing early breast cancer: the pathologist's perspective. Virchows
Arch 2011;458:125-31.
[3] Foschini MP, Flamminio F, Miglio R, et al. The impact of large
sections on the study of in situ and invasive duct carcinoma of the
breast. HUM PATHOL 2007;38:1736-43.
[4] Morandi L, Marucci G, Foschini MP, et al. Genetic similarities and
differences between lobular in situ neoplasia (LN) and invasive lobular
carcinoma of the breast. Virchows Arch 2006;449:14-23.
[5] Going JJ, Moffat DF. Escaping from flatland: clinical and biological
aspects of human mammary duct anatomy in three dimensions.
J Pathol 2004;203:538-44.
[6] Tot T. DCIS, cytokeratins, and the theory of the sick lobe. Virchows
Arch 2005;447:1-8.
[7] Wellings SR, Jensen HM. On the origin and progression of ductal
carcinoma in the human breast. J Natl Cancer Inst 1973;50:1111-8.
[8] Tot T. The diffuse type of invasive lobular carcinoma of the breast:
morphology and prognosis. Virchows Arch 2003;443:718-24.
[9] Foschini MP, Righi A, Cucchi MC, et al. The impact of large
sections and 3D technique on the study of lobular in situ and
invasive carcinoma of the breast. Virchows Arch 2006;448:
256-61.
[10] Tot T, Gere M, Pekar G, et al. Breast cancer multifocality, disease
extent, and survival. HUM PATHOL 2011;42:1761-9.
[11] Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, Van De Vijver MJ, editors.
WHO Classification of Tumours of the Breast. 4th ed. Lyon: IARC
Press; 2012.
[12] Page DL, Rogers LW, Schuyler PA, Dupont WD, Jensen RA. The
natural history of ductal carcinoma in situ of the breast. In: Silverstein
MJ, editor. Ductal carcinoma in situ of the breast. 2nd ed. Philadelphia:
Lippincott; 2002. p. 17-21.
[13] Kimura M. A simple method for estimating evolutionary rate of base
substitution through comparative studies of nucleotide sequences. J
Mol Evol 1980;16:111-6.
[14] Tavassoli FA, Eusebi V. Tumors of the breast. 4 ed. Washington, DC:
American Registry of Pathology/AFIP; 2009.
[15] Elston CW, Ellis IO. Pathological prognostic factors in breast cancer.
1. The value of histological grade in breast cancer: experience from a
large study with long-term follow-up. Histopathology 1991;19:
403-10.
[16] Tot T. Clinical relevance of the distribution of the lesions in 500
consecutive breast cancer cases documented in large format histologic
sections. Cancer 2007;110:2551-60.
[17] Anderson S, Bankier AT, Barrel BG, et al. Sequence and organization
of the human mitochondrial genome. Nature 1981;290:457-65.
[18] MITOWEB. MITOMAP: A Human Mitochondrial Genome Database.
http://www.mitomap.org/MITOMAP Published 2012. Accessed 2012
May 10.
[19] Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for
biologist programmers. In: Krawetz S, Misener S, editors. Bioinfor-
matics Methods and Protocols: Methods in Molecular Biology.
1319Field cancerization of duct breast carcinomaTotowa, NJ: Humana Press; 2000. p. 365-86. http://sourceforge.net/
projects/primer3/.
[20] Woischnik M, Moraes CT. Pattern of organization of human
mitochondrial pseudogenes in the nuclear genome. Genome Res
2002;12:885-93.
[21] Kumar S, Gadagkar SR. Efficiency of the neighbor-joining method in
reconstructing deep and shallow evolutionary relationships in large
phylogenies. J Mol Evol 2000;51:544-53.
[22] Saitou N, Nei M. The neighbor joining method: a new method to
reconstructing phylogenetic trees. Mol Biol Evol 1987;4:406-25.
[23] Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular
Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol
Biol Evol 2007;24:1596-9.
[24] Morandi L, Asioli S, Cavazza A, Pession A, Damiani S. Genetic
relationship among atypical adenomatous hyperplasia, bronchioloal-
veolar carcinoma and adenocarcinoma of the lung. Lung Cancer
2007;56:35-42.
[25] Foschini MP, Morandi L, Marchetti C, et al. Cancerization of
cutaneous flap reconstruction for oral squamous cell carcinoma: report
of three cases studied with the mtDNA D-loop sequence analysis.
Histopathology 2011;58:361-7.
[26] Morandi L, Pession A, Marucci G, et al. Intraepidermal cells of Paget's
carcinoma of the breast can be genetically different from those of the
underlying carcinoma. HUM PATHOL 2003;34:1321-30.
[27] Carrel L, Willard HF. X-inactivation profile reveals extensive variability
in X-linked gene expression in females. Nature 2005;434:400-4.[28] Salk JJ, Horwitz MS. Passenger mutations as a marker of clonal cell
lineages in emerging neoplasia. Semin Cancer Biol 2010;20:294-303.
[29] Pai SI, Westra WH. Molecular pathology of head and neck cancer:
implications for diagnosis, prognosis, and treatment. Ann Rev Pathol
2009;4:49-70.
[30] Dworkin AM, Huang TH, Toland AE. Epigenetic alterations in the
breast: implications for breast cancer detection, prognosis and
treatment. Semin Cancer Biol 2009;19:165-71.
[31] Slaughter DP, Southwick HW, Smeejkal W. Field cancerization in oral
stratified squamous epithelium; clinical implications of multicentric
origin. Cancer 1953;6:963-8.
[32] Ha PK, Califano JA. The molecular biology of mucosal field canceriza-
tion of the head and neck. Crit Rev Oral Biol Med 2003;14:363-9.
[33] Hitt R, Echarri MJ. Molecular biology in head and neck cancer. Clin
Transl Oncol 2006;8:776-9.
[34] Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of
head and neck cancer. Nat Rev Cancer 2011;11:9-22.
[35] Volante M, Sapino A, Croce S, Bussolati G. Heterogeneous versus
homogeneous genetic nature of multiple foci of in situ carcinoma of
the breast. HUM PATHOL 2003;34:1163-9.
[36] Aulmann S, Penzel R, Longerich T, Funke B, Schirmacher P, Sinn HP.
Clonality of lobular carcinoma in situ (LCIS) and metachronous
invasive breast cancer. Breast Cancer Res Treat 2008;107:331-5.
[37] Heaphy CM, Griffith JK, Bisoffi M. Mammary field cancerization:
molecular evidence and clinical importance. Breast Cancer Res Treat
2009;118:229-39.
